5 years ago at age 64, I was diagnosed with Stage 1 mutifocal invasive dcis. For that reason, I very unhappily had to have a mastectomy instead of lumpectomy. 2 sentinel lymph nodes were removed and were clear.
Arimidex was strongly suggested to me by one oncologist. I wasn't comfortable hearing about all the side effects. I got a second opinion from one of the top oncologists at the University of Pittsburgh Medical Center. He does extensive research and reading of all the global studies. To make a long story short, he said that all the studies showed little to no difference in survival rates if the cancer were to return in my remaining breast. He said many women choose not to take it for that reason. After much thought, I decided against Arimidex. I obviously am closely monitored, and have been happy with my personal decision. The survival rates were the deciding factor for me.